Jean Luc Dubois-Randé

Cardioprotective Effect of Morphine and a Blocker of Glycogen Synthase Kinase 3β, SB216763 [3-(2,4-Dichlorophenyl)-4(1-methyl-1 H-indol-3-yl)-1 H-pyrrole-2,5-dione], via Inhibition of the Mitochondrial Permeability Transition Pore

Fatou Nsoure Obame, Catherine Plin-Mercier, Rana Assaly et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 107 citations

Myocardial β-Adrenergic Desensitization and Neuronal Norepinephrine Uptake Function in Idiopathic Dilated Cardiomyopathy

Pascal Merlet, Jean Luc Dubois-Randé, Serge Adnot et al. · Journal of Cardiovascular Pharmacology · 1992 · 89 citations

The French randomized optimal stenting trial: a prospective evaluation of provisional stenting guided by coronary velocity reserve and quantitative coronary angiography

Antoine Lafont, Jean Luc Dubois-Randé, Philippe Gabríel Steg et al. · Journal of the American College of Cardiology · 2000 · 47 citations

Percutaneous Coronary Intervention, Endovascular Technique, Cardiovascular Disease +12

p21-Dependent Protective Effects of a Carbon Monoxide–Releasing Molecule-3 in Pulmonary Hypertension

Shariq Abid, Amal Houssaïni, Nathalie Mouraret et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2013 · 41 citations

Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial)

Nathan Mewton, Thien Tri Cung, Olivier Morel et al. · American Heart Journal · 2015 · 36 citations

Cardiovascular Disease, Cardiovascular Pharmacology, Clinical Trials +8